The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs

Jarir Atthobari, T.B.M. Monster, P.E. de Jong, Lolkje Theodora Wilhelmina de Jong-van den Berg*, PREVEND Study Group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)
Original languageEnglish
Pages (from-to)328-336
Number of pages9
JournalBritish Journal of Clinical Pharmacology
Volume57
Issue number3
DOIs
Publication statusPublished - 2004

Keywords

  • blood pressure lowering drug
  • general practitioner
  • hyperlipidemia
  • hypertension
  • incidence
  • intervention
  • letter
  • lipid lowering drug
  • patient
  • population screening
  • predictor variable
  • prevalence
  • URINARY ALBUMIN EXCRETION
  • CORONARY HEART-DISEASE
  • NONDIABETIC POPULATION
  • GENERAL-PRACTITIONERS
  • PRESCRIBING BEHAVIOR
  • POSTAL PROMPTS
  • RISK-FACTORS
  • MANAGEMENT
  • GUIDELINES
  • STROKE

Cite this